|
1
|
He X, Gao Z, Xu H, Zhang Z and Fu P: A
meta-analysis of randomized control trials of surgical methods with
osteosarcoma outcomes. J Orthop Surg Res. 12:52017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Isakoff MS, Bielack SS, Meltzer P and
Gorlick R: Osteosarcoma: Current treatment and a collaborative
pathway to success. J Clin Oncol. 33:3029–3035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
4
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morel AP, Hinkal GW, Thomas C, Fauvet F,
Courtois-Cox S, Wierinckx A, Devouassoux-Shisheboran M, Treilleux
I, Tissier A, Gras B, et al: EMT inducers catalyze malignant
transformation of mammary epithelial cells and drive tumorigenesis
towards claudin-low tumors in transgenic mice. PLoS Genet.
8:e10027232012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Amatangelo MD, Goodyear S and Varma D:
c-Myc expression and MEK1-induced Erk2 nuclear localization are
required for TGF-beta induced epithelial-mesenchymal transition and
invasion in prostate cancer. Carcinogenesis. 33:1965–1975. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharili AS, Allen S, Smith K, Price J and
McGonnell IM: Snail2 promotes osteosarcoma cell motility through
remodelling of the actin cytoskeleton and regulates tumor
development. Cancer Lett. 333:170–179. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsujii M, Kawano S and Dubois RN:
Cyclooxygenase-2 expression in human colon cancer cells increases
metastatic potential. Proc Natl Acad Sci USA. 94:3336–3340. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsujii M, Kawano S, Tsuji S, Sawaoka H,
Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced
by colon cancer cells. Cell. 93:705–716. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Masi L, Recenti R, Silvestri S, Pinzani P,
Pepi M, Paglierani M, Brandi ML and Franchi A: Expression of
cyclooxygenase-2 in osteosarcoma of bone. Appl Immunohistochem Mol
Morphol. 15:70–76. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rodriguez NI, Hoots WK, Koshkina NV,
Morales-Arias JA, Arndt CA, Inwards CY, Hawkins DS, Munsell MF and
Kleinerman ES: COX-2 expression correlates with survival in
patients with osteosarcoma lung metastases. J Pediatr Hematol
Oncol. 30:507–512. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pang LY, Gatenby EL, Kamida A, Whitelaw
BA, Hupp TR and Argyle DJ: Global gene expression analysis of
canine osteosarcoma stem cells reveals a novel role for COX-2 in
tumour initiation. PLoS One. 9:e831442014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee EJ, Choi EM, Kim SR, Park JH, Kim H,
Ha KS, Kim YM, Kim SS, Choe M, Kim JI and Han JA: Cyclooxygenase-2
promotes cell proliferation, migration and invasion in U2OS human
osteosarcoma cells. Exp Mol Med. 39:469–476. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Urakawa H, Nishida Y, Naruse T, Nakashima
H and Ishiguro N: Cyclooxygenase-2 overexpression predicts poor
survival in patients with high-grade extremity osteosarcoma: A
pilot study. Clin Orthop Relat Res. 467:2932–2938. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ji C, Guo H, Zhang P, Kuang W, Fan Y and
Wu L: AnnexinA5 promote glioma cell invasion and migration via the
PI3K/Akt/NF-κB signaling pathway. J Neurooncol. 138:469–478. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu LB, Jiang J, Zhu XP, Wang TF, Chen XY,
Luo QF, Shu Y, Liu ZL and Huang SH: Knockdown of Aurora-B inhibits
osteosarcoma cell invasion and migration via modulating
PI3K/Akt/NF-κB signaling pathway. Int J Clin Exp Pathol.
7:3984–3991. 2014.PubMed/NCBI
|
|
17
|
Dong Y, Liang G, Yuan B, Yang C, Gao R and
Zhou X: MALAT1 promotes the proliferation and metastasis of
osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol.
36:1477–1486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He ML, Wu Y, Zhao JM, Wang Z and Chen YB:
PIK3CA and AKT gene polymorphisms in susceptibility to osteosarcoma
in a Chinese population. Asian Pac J Cancer Prev. 14:5117–5122.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Orgaz JL, Ladhani O, Hoek KS,
Fernández-Barral A, Mihic D, Aguilera O, Seftor EA, Bernad A,
Rodríguez-Peralto JL, Hendrix MJ, et al: ‘Loss of pigment
epithelium-derived factor enables migration, invasion and
metastatic spread of human melanoma’. Oncogene. 28:4147–4161. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luan W, Yao Q, Xin N, Bu X, Xia Y, Wang J,
Ruan H, Ma S and Xu B: miR-204-5p acts as a tumor suppressor by
targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in
malignant melanoma. Onco Targets Ther. 10:1237–1246. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vincent CT and Fuxe J: EMT, inflammation
and metastasis. Semin Cancer Biol. 47:168–169. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y and Zhou BP: New insights of
epithelial-mesenchymal transition in cancer metastasis. Acta
Biochim Biophys Sin (Shanghai). 40:643–650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Amano S, Akutsu N, Matsunaga Y, Nishiyama
T, Champliaud MF, Burgeson RE and Adachi E: Importance of balance
between extracellular matrix synthesis and degradation in basement
membrane formation. Exp Cell Res. 271:249–262. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liao CL, Chu YL, Lin HY, Chen CY, Hsu MJ,
Liu KC, Lai KC, Huang AC and Chung JG: Bisdemethoxycurcumin
suppresses migration and invasion of human cervical cancer HeLa
cells via inhibition of NF-ĸB, MMP-2 and −9 pathways. Anticancer
Res. 38:3989–3997. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu S, Yang D, Beckford J and Alachkar H:
Upregulation of the EMT marker vimentin is associated with poor
clinical outcome in acute myeloid leukemia. J Transl Med.
16:1702018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gou Y, Zhai F, Zhang L and Cui L: RUNX3
regulates hepatocellular carcinoma cell metastasis via targeting
miR-186/E-cadherin/EMT pathway. Oncotarget. 8:61475–61486. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao G, Cai C, Yang T, Qiu X, Liao B, Li
W, Ji Z, Zhao J, Zhao H, Guo M, et al: MicroRNA-221 induces cell
survival and cisplatin resistance through PI3K/Akt pathway in human
osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo YS, Zhao R, Ma J, Cui W, Sun Z, Gao B,
He S, Han YH, Fan J, Yang L, et al: βig-h3 promotes human
osteosarcoma cells metastasis by interacting with integrin α2β1 and
activating PI3K signaling pathway. PLoS One. 9:e902202014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hou CH, Lin FL, Tong KB, Hou SM and Liu
JF: Transforming growth factor alpha promotes osteosarcoma
metastasis by ICAM-1 and PI3K/Akt signaling pathway. Biochem
Pharmacol. 89:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aizawa J, Sakayama K, Kamei S, Kidani T,
Yamamoto H, Norimatsu Y and Masuno H: Effect of troglitazone on
tumor growth and pulmonary metastasis development of the mouse
osteosarcoma cell line LM8. BMC Cancer. 10:512010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsubaki M, Satou T, Itoh T, Imano M, Ogaki
M, Yanae M and Nishida S: Reduction of metastasis, cell invasion,
and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced
blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway. Toxicol Appl
Pharmacol. 259:402–410. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li J, Lau GK, Chen L, Dong SS, Lan HY,
Huang XR, Li Y, Luk JM, Yuan YF and Guan XY: Interleukin 17A
promotes hepatocellular carcinoma metastasis via NF-kB induced
matrix metalloproteinases 2 and 9 expression. PLoS One.
6:e218162011. View Article : Google Scholar : PubMed/NCBI
|
